# Celltrion plans $1.4B US plant expansion and $3.4B domestic investment

Celltrion announced a 1.4 trillion won investment to acquire and expand its Branchburg, New Jersey plant to 66,000 liters capacity, and a 4 trillion won investment in new domestic facilities in Songdo, Yesan, and Ochang.

- Type: Expansion
- Announced: 2025-11-19
- Where: Branchburg, New Jersey, United States
- Value: $1.00B (1400.0B KRW)
- Status: announced
- Capacity: 66,000 liters
- Products: biopharmaceuticals, antibody-drug conjugates, obesity treatments
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Celltrion](https://endata.com/companies/15585.md)

## Sources

- [asiae.co.kr](https://www.asiae.co.kr/en/article/2025111910210517489), 2025-11-19: "Celltrion intends to invest a total of 1.4 trillion won, including 700 billion won for the acquisition and an additional 700 billion won for expansion, to increase production capacity to up to 66,000 liters over five years."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.